Abstract:ABSTRACT Previous studies have shown that the gut microbiota and its metabolites are associated with the success of organ transplantation. However, the specific changes in the gut microbiota of lung transplant patients remain unclear. Hence, this study aimed to elucidate the interplay between the gut microbiota, metabolome, and lung transplantation outcomes. Using 16S metagenomics sequencing and untargeted metabolic profiling, we conducted a comprehensive analysis of gut microbial and metabolic alterations in lung transplant recipients relative to non-transplant group. Our findings revealed the predominance of Enterococcus and Streptococcus genera within the lung transplant cohort, accompanied by the significant reduction in Bacteroides , Epulopiscium , Faecalibacterium , and Prevotella abundance. In addition, a significant reduction in ATRA (all-trans retinoic acid) levels and suppression of IgA production were observed in lung transplant recipients, which were found to be closely associated with the Enterococcus genus. It was speculated that the association might have implications for the prognosis of lung transplant patients. Notably, the differences in gut microbial composition and metabolomic profiles between successful transplant recipients and those experiencing chronic rejection were not statistically significant. These novel insights shed light on the putative implications of the gut microbiota and metabolome in shaping lung transplantation outcomes, and provide a foundation for future investigations and targeted therapeutic interventions. IMPORTANCE This study has profound implications for lung transplantation as it uncovers the important role of gut microbiota and metabolome in shaping transplantation outcomes. The identification of dominant bacterial genera, such as Enterococcus and Streptococcus , within the lung transplant cohort, along with the significant decrease in Bacteroides , Epulopiscium , Faecalibacterium , and Prevotella abundance, reveals potential microbial imbalances associated with lung transplantation. In addition, a significant reduction in ATRA (all-trans retinoic acid) levels and suppression of IgA production were observed in lung transplant recipients, which were found to be closely associated with the Enterococcus genus. It was speculated that the association might have implications for the prognosis of lung transplant patients. These findings hold immense clinical significance as they lay the groundwork for future research and targeted therapeutic interventions. Understanding the impact of the gut microbiota and metabolome on lung transplantation outcomes offers promising avenues for improving transplantation patient prognosis.

Organ transplantation and gut microbiota: current reviews and future challenges

Gut microbiota and allogeneic transplantation

Kidney transplantation and gut microbiota

Gut Microbiota and Its Implications in Small Bowel Transplantation

Fecal microbiota transplantation in clinical practice: Present controversies and future prospects

Gut Microbial Dysbiosis and Implications in Solid Organ Transplantation

Interaction between ischemia-reperfusion injury and intestinal microecology in organ transplantation and its therapeutic prospects

Regulation of Gut Microbiota: a Novel Pretreatment for Complications in Patients Who Have Undergone Kidney Transplantation

Solid organ transplantation and gut microbiota: a review of the potential immunomodulatory properties of short-chain fatty acids in graft maintenance

The Role of Intestinal Microbiota in Acute Graft-versus-Host Disease

Effect of Immunosuppressive Therapy After Liver Transplantation and the Relationship Between Changes in the Gut Microbiome and Graft Rejection

Unraveling Intestinal Microbial Shifts in ESRD and Kidney Transplantation: Implications for Disease-Related Dysbiosis

Analysis on the change of gut microbiota and metabolome in lung transplant patients

The Gut Microbiota in Liver Transplantation Recipients During the Perioperative Period

Gut Microbiota Modulation: A Viable Strategy to Address Medical Needs in Hepatocellular Carcinoma and Liver Transplantation

The Impact of Human Microbiotas in Hematopoietic Stem Cell and Organ Transplantation

The Progress of Alteration of Intestinal Flora after Liver Transplantation

Gut Microbiome Dysbiosis is Associated with Increased Mortality Following Solid Organ Transplantation

Structural Shifts of Fecal Microbial Communities in Rats with Acute Rejection after Liver Transplantation

Gut microbiota, microbiota‐derived metabolites, and graft‐versus‐host disease

Microbiosis in Lung Allotransplantation and Xenotransplantation: State of the Art and Future Perspective